Q5126 Inj alymsys 10 mg

Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 230 units per day (practitioner), rationale: CMS Policy